WVE — Wave Life Sciences Balance Sheet
0.000.00%
- $611.15m
- $438.10m
- $113.31m
Annual balance sheet for Wave Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 147 | 184 | 151 | 88.5 | 200 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 20 | 30 | 0 | — | 21.1 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 185 | 230 | 163 | 98.5 | 235 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 54.5 | 45.4 | 40.6 | 44.1 | 35.7 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 284 | 279 | 207 | 146 | 275 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 118 | 121 | 64.2 | 71.5 | 186 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 213 | 189 | 167 | 184 | 227 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 71.6 | 90.7 | 40.4 | -37.2 | 47.5 |
Total Liabilities & Shareholders' Equity | 284 | 279 | 207 | 146 | 275 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |